MedPath

Comparative study on effect of alkaline preparation of two species of chiraita processed in Buffalo urine in loss of digestive power.

Phase 3
Not yet recruiting
Conditions
Disease of digestive system, unspecified,
Registration Number
CTRI/2019/01/017047
Lead Sponsor
National Institute of Ayurveda
Brief Summary

Ayurveda views the health of an individual as the proper functioning of Agni(digestive fire inside body). Agnimandhya is the pathological state of inhibited agni.As per Acharya Baghbhat Agnimandhya leads to manifestation of all types of diseases. Kshar is prescribed to cure Agnimandhya . Acharya Charak has described Bhunimbadi kshar to cure Agnimandhya. In this study kshar of two species of chiraita (bhunimb) i. e Swertia chirayata and Swertia angustifolia  are taken. The study aims to compare the effectiveness of both drugs.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria
  • 1.Patients having classical signs and symptoms of jatharagnimandhya like Avipaka, Chardi, Angamard, Udara Gaurav, Ksudhanasa, Mukha durgandha, etc will be selected.
  • 2.Patients of either sex with age group between 20 to 70 years will be selected.
Exclusion Criteria
  • Patients with chronic disease like severe Hypertension, IHD, COPD, DM, cancer, Hepatic and renal insufficiency, psychotic disorders like depression, schizophrenia.
  • 2.Any acute illness /serious illness.
  • 3.Pregnant women and lactating mothers.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in subjective and objective parameters.21days
Secondary Outcome Measures
NameTimeMethod
To find comparative efficacy of either treatment.21 days

Trial Locations

Locations (1)

National Institute of Ayurveda

🇮🇳

Jaipur, RAJASTHAN, India

National Institute of Ayurveda
🇮🇳Jaipur, RAJASTHAN, India
Dr Sabita Sapkota
Principal investigator
9587112737
sapkotasabita1988@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.